This enduring highlights national and local expert faculty discussing expanded oral small molecule treatment options for patients with moderate-to-severe plaque psoriasis and personalizing treatment selection and optimizing safety. As a result of this educational curriculum, learners should be better able to: 1. Identify patients with moderate to severe plaque psoriasis who would benefit from oral small molecule therapy; 2. Differentiate the targets/mechanisms of action of available oral small molecule therapy for moderate to severe plaque psoriasis; and, 3. Integrate strategies to individualize oral small molecule therapy for moderate to severe plaque psoriasis, while balancing safety, considering regional barriers. Learners have access to downloadable slides.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedDec 10, 2025
-
Last day to claim creditDec 10, 2026 2 months left
-
ScientiaCME A critical appraisal of present and emerging management approaches to moderate to severe plaque psoriasis in adults: going beyond skin-deep
-
American Academy of Sleep Medicine JCSM2026v22n3-Nocturnal hypoxemia is associated with increased urine Kidney Injury Molecule-1 (KIM-1) in patients with obstructive sleep apnea
-
The Ohio State University Moderate & Deep Sedation
-
Answers in CME Inc. (AiCME) Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing Care
-
Answers in CME Inc. (AiCME) Small Molecules, Big Decisions: Where Do TYK2 Inhibitors Fit in Psoriasis Treatment?
-
Answers in CME Inc. (AiCME) Redefining Oral Therapy in Psoriasis: TYK2 Inhibition in Focus
